Table 1. Incidence, intensity and thickness of gastric lesions in patients with PGL and AGC.

	ANHL(n = 24)	MALT (n = 14)	AGC (n = 69)
Presence of CT abnormalities	92% (22/24)	86% (12/14)	97% (67/69)
Presence of gastric FDGuptake	100% (24/24)	86% (12/14)	100% (69/69)
SUVmax	17.10±8.08*	6.20±3.60	9.65±5.24
THKmax (cm)	2.05±1.08	1.68±0.81	1.93±0.67

^*SUVmax for ANHL vs. AGC and ANHL vs. FDG-avid MALT were significantly different by ANCOVA, P<0.05; SUVmax: maximum standardized uptake value; THKmax: maximal thickness of tumor; FDG: fluorodeoxyglucose; AGC: advanced gastric cancer; MALT: mucosa-associated lymphoid tissue; ANHL: aggressive non-Hodgkin’s lymphoma; Data are mean ± SD or number (%).